OKX is pleased to announce the listing of Venom (VENOM) on its spot trading markets. Below is the detailed schedule:
Key Dates & Timeline
- VENOM Deposit Opens: 15:30 (UTC+7), March 22, 2024
- VENOM/USDT Spot Trading Begins: 15:00 (UTC+7), March 25, 2024
- VENOM Withdrawal Opens: 17:00 (UTC+7), March 26, 2024
About Venom Network
Venom is a Layer 0 blockchain designed to provide scalable, sustainable infrastructure for enterprise, government, and Web3 applications. Its architecture supports an independent economy through a unique network framework.
Token Details
- Asset Name: Venom
- Ticker: VENOM
- Total Supply: 7,200,000,000
Risk Disclaimer
Cryptocurrency trading involves significant risk due to market volatility. OKX does not guarantee the accuracy or completeness of third-party information provided in this announcement.
👉 Learn more about secure crypto trading
Users are advised to:
- Conduct independent research before trading.
- Assess personal risk tolerance.
- Avoid relying solely on promotional content for investment decisions.
Note: This announcement is not financial advice. Digital assets may not be suitable for all investors.
FAQs
1. When can I start trading VENOM on OKX?
Spot trading for VENOM/USDT opens at 15:00 (UTC+7), March 25, 2024.
2. What is the total supply of VENOM tokens?
The maximum supply is capped at 7.2 billion VENOM.
3. How does Venom Network differ from other blockchains?
Venom operates as a Layer 0 solution, focusing on enterprise-grade scalability and governance applications.
For further assistance, contact OKX Support via official channels.
OKX Team
March 22, 2024
### Key SEO Keywords:
1. Venom (VENOM)
2. OKX spot trading
3. Layer 0 blockchain
4. VENOM token listing
5. Cryptocurrency risk management
6. VENOM/USDT trading
7. Venom Network infrastructure
### Optimizations Applied:
- Removed redundant dates/years from the title.
- Structured content with Markdown headings for clarity.
- Integrated keywords naturally.
- Added FAQs and anchor texts for engagement.
- Ensured compliance with risk disclaimer guidelines.